Team receives $3.3M NIH award to study medication deprescribing

Submitted by rjholden on Thu, 11/07/2019 - 09:43

The R2D2 trial is an R01 led by Dr. Noll Campbell of the Purdue College of Pharmacy. It will test a pharmacy-based anticholinergic deprescribing intervention for older adults. Campbell co-directs the Brain Safety Lab with Dr. Holden.